Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 201

1.

Association of Anti-Porphyromonas gingivalis Antibody Titers With Nonsmoking Status in Early Rheumatoid Arthritis: Results From the Prospective French Cohort of Patients With Early Rheumatoid Arthritis.

Seror R, Le Gall-David S, Bonnaure-Mallet M, Schaeverbeke T, Cantagrel A, Minet J, Gottenberg JE, Chanson P, Ravaud P, Mariette X.

Arthritis Rheumatol. 2015 Jul;67(7):1729-37. doi: 10.1002/art.39118.

2.

Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis.

Mikuls TR, Payne JB, Yu F, Thiele GM, Reynolds RJ, Cannon GW, Markt J, McGowan D, Kerr GS, Redman RS, Reimold A, Griffiths G, Beatty M, Gonzalez SM, Bergman DA, Hamilton BC 3rd, Erickson AR, Sokolove J, Robinson WH, Walker C, Chandad F, O'Dell JR.

Arthritis Rheumatol. 2014 May;66(5):1090-100. doi: 10.1002/art.38348.

3.

Antibodies to porphyromonas gingivalis are associated with anticitrullinated protein antibodies in patients with rheumatoid arthritis and their relatives.

Hitchon CA, Chandad F, Ferucci ED, Willemze A, Ioan-Facsinay A, van der Woude D, Markland J, Robinson D, Elias B, Newkirk M, Toes RM, Huizinga TW, El-Gabalawy HS.

J Rheumatol. 2010 Jun;37(6):1105-12. doi: 10.3899/jrheum.091323. Epub 2010 May 1.

PMID:
20436074
4.

Antibodies to Porphyromonas gingivalis Indicate Interaction Between Oral Infection, Smoking, and Risk Genes in Rheumatoid Arthritis Etiology.

Kharlamova N, Jiang X, Sherina N, Potempa B, Israelsson L, Quirke AM, Eriksson K, Yucel-Lindberg T, Venables PJ, Potempa J, Alfredsson L, Lundberg K.

Arthritis Rheumatol. 2016 Mar;68(3):604-13. doi: 10.1002/art.39491.

5.

Periodontitis in established rheumatoid arthritis patients: a cross-sectional clinical, microbiological and serological study.

de Smit M, Westra J, Vissink A, Doornbos-van der Meer B, Brouwer E, van Winkelhoff AJ.

Arthritis Res Ther. 2012 Oct 17;14(5):R222. doi: 10.1186/ar4061.

6.

Clinical correlations with Porphyromonas gingivalis antibody responses in patients with early rheumatoid arthritis.

Arvikar SL, Collier DS, Fisher MC, Unizony S, Cohen GL, McHugh G, Kawai T, Strle K, Steere AC.

Arthritis Res Ther. 2013;15(5):R109.

7.

Porphyromonas gingivalis and disease-related autoantibodies in individuals at increased risk of rheumatoid arthritis.

Mikuls TR, Thiele GM, Deane KD, Payne JB, O'Dell JR, Yu F, Sayles H, Weisman MH, Gregersen PK, Buckner JH, Keating RM, Derber LA, Robinson WH, Holers VM, Norris JM.

Arthritis Rheum. 2012 Nov;64(11):3522-30. doi: 10.1002/art.34595.

8.

Defining the role of Porphyromonas gingivalis peptidylarginine deiminase (PPAD) in rheumatoid arthritis through the study of PPAD biology.

Konig MF, Paracha AS, Moni M, Bingham CO 3rd, Andrade F.

Ann Rheum Dis. 2015 Nov;74(11):2054-61. doi: 10.1136/annrheumdis-2014-205385. Epub 2014 May 26.

9.

Concentration of antibodies against Porphyromonas gingivalis is increased before the onset of symptoms of rheumatoid arthritis.

Johansson L, Sherina N, Kharlamova N, Potempa B, Larsson B, Israelsson L, Potempa J, Rantapää-Dahlqvist S, Lundberg K.

Arthritis Res Ther. 2016 Sep 7;18:201. doi: 10.1186/s13075-016-1100-4. Erratum in: Arthritis Res Ther. 2016 Nov 4;18(1):257.

10.

Association between anti-Porphyromonas gingivalis or anti-α-enolase antibody and severity of periodontitis or rheumatoid arthritis (RA) disease activity in RA.

Lee JY, Choi IA, Kim JH, Kim KH, Lee EY, Lee EB, Lee YM, Song YW.

BMC Musculoskelet Disord. 2015 Aug 12;16:190. doi: 10.1186/s12891-015-0647-6.

11.

Smoking, Porphyromonas gingivalis and the immune response to citrullinated autoantigens before the clinical onset of rheumatoid arthritis in a Southern European nested case-control study.

Fisher BA, Cartwright AJ, Quirke AM, de Pablo P, Romaguera D, Panico S, Mattiello A, Gavrila D, Navarro C, Sacerdote C, Vineis P, Tumino R, Lappin DF, Apatzidou D, Culshaw S, Potempa J, Michaud DS, Riboli E, Venables PJ.

BMC Musculoskelet Disord. 2015 Nov 4;16:331. doi: 10.1186/s12891-015-0792-y. Erratum in: BMC Musculoskelet Disord. 2016;17:62. Apazidou, Danae [corrected to Apatzidou, Danae].

12.

Antibody responses to Porphyromonas gingivalis (P. gingivalis) in subjects with rheumatoid arthritis and periodontitis.

Mikuls TR, Payne JB, Reinhardt RA, Thiele GM, Maziarz E, Cannella AC, Holers VM, Kuhn KA, O'Dell JR.

Int Immunopharmacol. 2009 Jan;9(1):38-42. doi: 10.1016/j.intimp.2008.09.008. Epub 2008 Oct 9.

13.

Missing Anticitrullinated Protein Antibody Does Not Affect Short-term Outcomes in Early Inflammatory Arthritis: From the Canadian Early Arthritis Cohort.

Shu J, Bykerk VP, Boire G, Haraoui B, Hitchon C, Thorne JC, Tin D, Keystone EC, Pope JE; CATCH Investigators.

J Rheumatol. 2015 Nov;42(11):2023-8. doi: 10.3899/jrheum.150260. Epub 2015 Sep 1.

PMID:
26329342
14.

Porphyromonas gingivalis may play an important role in the pathogenesis of periodontitis-associated rheumatoid arthritis.

Liao F, Li Z, Wang Y, Shi B, Gong Z, Cheng X.

Med Hypotheses. 2009 Jun;72(6):732-5. doi: 10.1016/j.mehy.2008.12.040. Epub 2009 Feb 25.

PMID:
19246161
15.

Serum Immunoglobulin G Levels to Porphyromonas gingivalis Peptidylarginine Deiminase Affect Clinical Response to Biological Disease-Modifying Antirheumatic Drug in Rheumatoid Arthritis.

Kobayashi T, Ito S, Kobayashi D, Shimada A, Narita I, Murasawa A, Nakazono K, Yoshie H.

PLoS One. 2016 Apr 25;11(4):e0154182. doi: 10.1371/journal.pone.0154182. eCollection 2016.

16.

Antibody responses to periodontopathic bacteria in relation to rheumatoid arthritis in Japanese adults.

Okada M, Kobayashi T, Ito S, Yokoyama T, Komatsu Y, Abe A, Murasawa A, Yoshie H.

J Periodontol. 2011 Oct;82(10):1433-41. doi: 10.1902/jop.2011.110020. Epub 2011 Feb 22.

PMID:
21342003
17.

Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis.

Scher JU, Ubeda C, Equinda M, Khanin R, Buischi Y, Viale A, Lipuma L, Attur M, Pillinger MH, Weissmann G, Littman DR, Pamer EG, Bretz WA, Abramson SB.

Arthritis Rheum. 2012 Oct;64(10):3083-94. doi: 10.1002/art.34539.

18.

Influence of periodontal disease, Porphyromonas gingivalis and cigarette smoking on systemic anti-citrullinated peptide antibody titres.

Lappin DF, Apatzidou D, Quirke AM, Oliver-Bell J, Butcher JP, Kinane DF, Riggio MP, Venables P, McInnes IB, Culshaw S.

J Clin Periodontol. 2013 Oct;40(10):907-15. doi: 10.1111/jcpe.12138. Epub 2013 Aug 1.

PMID:
23902301
19.

FCRL3 -169C/C genotype is associated with anti-citrullinated protein antibody-positive rheumatoid arthritis and with radiographic progression.

Maehlen MT, Nordang GB, Syversen SW, van der Heijde DM, Kvien TK, Uhlig T, Lie BA.

J Rheumatol. 2011 Nov;38(11):2329-35. doi: 10.3899/jrheum.110489. Epub 2011 Sep 1.

PMID:
21885492
20.

Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies.

Jiang X, Trouw LA, van Wesemael TJ, Shi J, Bengtsson C, Källberg H, Malmström V, Israelsson L, Hreggvidsdottir H, Verduijn W, Klareskog L, Alfredsson L, Huizinga TW, Toes RE, Lundberg K, van der Woude D.

Ann Rheum Dis. 2014 Oct;73(10):1761-8. doi: 10.1136/annrheumdis-2013-205109. Epub 2014 May 8.

PMID:
24812286

Supplemental Content

Support Center